Moderna's Revenue by Segment
In fiscal year 2025, Moderna's revenue by segment (products & services) are as follows:
- Product Sales: $3.30 B
Learn more about Moderna’s Revenue by Geography
Check out competitors to Moderna in a side-by-side comparison.
Explore additional financial metrics for Moderna.
Moderna's Revenue Share by Segment
| Messenger RNA (mRNA) Medicines | 6848000000 |
|---|
| Collaboration Arrangement | 12000000 |
|---|---|
| Grant | 37000000 |
| Product Sales | 4517000000 |
| Product Sales | 3304000000 |
|---|
The above chart shows Moderna's revenue percentage share by segment (products and services).
In fiscal year 2023, Moderna's revenue by segment is as follows:
- Messenger RNA (mRNA) Medicines generated $6.85 B in revenue, representing 100% of its total revenue.
The biggest segment for Moderna is the Messenger RNA (mRNA) Medicines, which represents 100% of its total revenue.
The smallest segment for Moderna is the Messenger RNA (mRNA) Medicines, which represents 100% of its total revenue.
The above chart shows Moderna's revenue percentage share by segment (products and services).
In fiscal year 2024, Moderna's revenue by segment is as follows:
- Collaboration Arrangement generated $12.00 M in revenue, representing 0.26% of its total revenue.
- Grant generated $37.00 M in revenue, representing 0.81% of its total revenue.
- Product Sales generated $4.52 B in revenue, representing 98.93% of its total revenue.
The biggest segment for Moderna is the Product Sales, which represents 98.93% of its total revenue.
The smallest segment for Moderna is the Collaboration Arrangement, which represents 0.26% of its total revenue.
The above chart shows Moderna's revenue percentage share by segment (products and services).
In fiscal year 2025, Moderna's revenue by segment is as follows:
- Product Sales generated $3.30 B in revenue, representing 100% of its total revenue.
The biggest segment for Moderna is the Product Sales, which represents 100% of its total revenue.
The smallest segment for Moderna is the Product Sales, which represents 100% of its total revenue.
Summary Table
| Products & Services (Percent Share) | 2023 | 2024 | 2025 |
|---|---|---|---|
| Messenger RNA (mRNA) Medicines | 100% | - | - |
| Collaboration Arrangement | - | 0.26% | - |
| Grant | - | 0.81% | - |
| Product Sales | - | 98.93% | 100% |
| Total Revenue | 100% | 100% | 100% |
Moderna's Segments Revenue Trend
The above chart shows the revenue trend of different segments of Moderna.
In fiscal year 2025, the Product Sales generated the most revenue ($3.30 B), and the Product Sales generated the least revenue ($3.30 B).
Moderna's Revenue Growth Drivers
The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.
Summary Table
Related
-
Agilent Technologies Revenue by Segment
-
Eli Lilly and Company Revenue by Segment
-
Stryker Corporation Revenue by Segment
-
Johnson & Johnson Revenue by Segment
-
AbbVie Revenue by Segment
-
Merck & Co. Revenue by Segment
-
Thermo Fisher Scientific Revenue by Segment
-
Abbott Laboratories Revenue by Segment
-
Danaher Corporation Revenue by Segment
-
Amgen Revenue by Segment
